Catalyst Pharmaceuticals Inc (CPRX)
21.12
-0.02
(-0.12%)
USD |
NASDAQ |
Nov 21, 16:00
21.12
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Price to Book Value: 3.812 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.817 |
| November 19, 2024 | 3.86 |
| November 18, 2024 | 3.757 |
| November 15, 2024 | 3.718 |
| November 14, 2024 | 3.914 |
| November 13, 2024 | 4.114 |
| November 12, 2024 | 4.158 |
| November 11, 2024 | 4.232 |
| November 08, 2024 | 4.318 |
| November 07, 2024 | 4.196 |
| November 06, 2024 | 4.098 |
| November 05, 2024 | 3.963 |
| November 04, 2024 | 3.925 |
| November 01, 2024 | 3.95 |
| October 31, 2024 | 3.934 |
| October 30, 2024 | 3.890 |
| October 29, 2024 | 3.928 |
| October 28, 2024 | 3.945 |
| October 25, 2024 | 3.872 |
| October 24, 2024 | 3.863 |
| October 23, 2024 | 3.851 |
| October 22, 2024 | 3.872 |
| October 21, 2024 | 3.793 |
| October 18, 2024 | 3.833 |
| October 17, 2024 | 3.818 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.910 |
| October 15, 2024 | 3.822 |
| October 14, 2024 | 3.724 |
| October 11, 2024 | 3.645 |
| October 10, 2024 | 3.593 |
| October 09, 2024 | 3.604 |
| October 08, 2024 | 3.623 |
| October 07, 2024 | 3.560 |
| October 04, 2024 | 3.609 |
| October 03, 2024 | 3.587 |
| October 02, 2024 | 3.609 |
| October 01, 2024 | 3.649 |
| September 30, 2024 | 3.587 |
| September 27, 2024 | 3.814 |
| September 26, 2024 | 3.890 |
| September 25, 2024 | 3.90 |
| September 24, 2024 | 3.998 |
| September 23, 2024 | 3.996 |
| September 20, 2024 | 4.054 |
| September 19, 2024 | 4.163 |
| September 18, 2024 | 3.984 |
| September 17, 2024 | 3.986 |
| September 16, 2024 | 3.986 |
| September 13, 2024 | 3.943 |
| September 12, 2024 | 3.957 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.965
Minimum
Sep 30 2020
7.515
Maximum
Dec 21 2022
3.967
Average
3.821
Median
Price to Book Value Benchmarks
| Corcept Therapeutics Inc | 9.178 |
| Vertex Pharmaceuticals Inc | 7.420 |
| Sarepta Therapeutics Inc | 8.645 |
| ADMA Biologics Inc | 21.71 |
| BioVie Inc | 3.916 |
Price to Book Value Related Metrics
| PE Ratio | 17.90 |
| PS Ratio | 5.588 |
| PEG Ratio | 0.1410 |
| Price to Free Cash Flow | 11.60 |
| Price | 21.12 |
| Earnings Yield | 5.59% |
| Market Cap | 2.520B |
| PEGY Ratio | 0.1410 |
| Operating PE Ratio | 14.79 |
| Normalized PE Ratio | 17.86 |